WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism
Clinical trial NCT03297359 · TERMINATED
Trial details
- NCT number
- NCT03297359
- Sponsor
- Ottawa Hospital Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2023-11-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.